Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.

MLA

UCL - SSS/IREC/GAEN - Pôle d’Hépato-gastro-entérologie, et al. “Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.” JAMA Network Open, Vol. 4, No. 10, p. E2129639 (2021), 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1288275023&authtype=sso&custid=ns315887.

APA

UCL - SSS/IREC/GAEN - Pôle d’Hépato-gastro-entérologie, UCL - (MGD) Service de gastro-entérologie, Izadi, Z., Brenner, E. J., Mahil, S. K., Dand, N., Yiu, Z. Z. N., Yates, M., Ungaro, R. C., Zhang, X., Agrawal, M., Colombel, J.-F., Gianfrancesco, M. A., Hyrich, K. L., Strangfeld, A., Carmona, L., Mateus, E. F., Lawson-Tovey, S., Klingberg, E., … Rahier, J.-F. (2021). Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19. JAMA Network Open, Vol. 4, No. 10, p. E2129639 (2021).

Chicago

UCL - SSS/IREC/GAEN - Pôle d’Hépato-gastro-entérologie, UCL - (MGD) Service de gastro-entérologie, Zara Izadi, Erica J Brenner, Satveer K Mahil, Nick Dand, Zenas Z N Yiu, et al. 2021. “Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.” JAMA Network Open, Vol. 4, No. 10, p. E2129639 (2021). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1288275023&authtype=sso&custid=ns315887.